Efficacy and safety of Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B with High Baseline Viral Load
Background: Chronic hepatitis B virus infection is an important cause of morbidity and mortality. Tenofovir disoproxil fumarate was licensed for the treatment of hepatitis B virus infection. So, the current study aimed to Evaluate efficacy and outcome of Tenofovir Disoproxil Fumarate in patients wit...
Main Authors: | Ahmed Gad Mohamed Ahmed*, Ali Abdel Rahman Sayed Ghweil, Hasan Sedeek Mahmoud |
---|---|
Format: | Article |
Language: | English |
Published: |
South Valley University, Faculty of Medicine
2020-07-01
|
Series: | SVU - International Journal of Medical Sciences |
Subjects: | |
Online Access: | https://svuijm.journals.ekb.eg/article_111898.html |
Similar Items
-
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
by: Giacomo Stroffolini, et al.
Published: (2024-02-01) -
Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
by: Na Yang, et al.
Published: (2021-08-01) -
Antiviral Efficacy and Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B
by: Tuvshinbayar Narangerel, et al.
Published: (2020-12-01) -
Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
by: Hyeyeon Hong, et al.
Published: (2024-01-01) -
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate [version 2; peer review: 2 approved]
by: Putri Chairani Eyanoer, et al.
Published: (2023-08-01)